490 Results (Page 20 of 20)
Canada Markets Research Reports
Canada Congestive Heart Failure Therapeutics Market Analysis
The Canada Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $0.824 Bn in 2022 to $1.294 Bn by 2030, with a CAGR of 5.8% during the forecast period of 2022-2030. The key drivers of the Canadian congestive Heart Failure Therapeutics Market include the increasing prevalence of risk factors leading to CVS disorders, advancements in medical technology and intervention options, and supportive government schemes and reimbursement strategies. The Canada Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including AbbVie, Amgen, AstraZeneca, Bayer, Bristol Myers Squibb, Johnson & Johnson, Apotex, Paladin Labs, Pharmascience, Sandoz, etc, among various others.
Canada Medication Access Programs Market Analysis
The Canada Medication Access Programs Market was valued at $439.2 Mn in 2023 and is predicted to grow at a CAGR of 14.6% from 2023 to 2030, to $1140 Mn by 2030. The key drivers of this industry include chronic disease prevalence, rising healthcare costs, and pharmaceutical support. The industry is primarily dominated by players such as Gilead Sciences, Takeda Pharmaceuticals, Pfizer, and Novartis among others.
Canada Cancer Induced Bone Diseases Therapeutics Market
Canada Cancer Induced Bone Disease Therapeutics Market valued at $104 Mn in 2022, projected to reach $163 Mn by 2030 with a 5.8% CAGR. The key drivers of this industry include rising cancer incidence, increased research and development, and advancements in cancer diagnostics. The industry is primarily dominated by players such as Amgen, Pfizer, Merck, Eli Lilly, Novartis, Bayer, and Johnson & Johnson, among others.
Canada Car T-Cell Therapy Market
Canada Car T-Cell Therapy Market valued at $232 Mn in 2022, projected to reach $393 Mn by 2030 with a 6.8% CAGR. The growing occurrence and prevalence of cancer worldwide, driven by factors like population aging, unhealthy lifestyles, and environmental influences, contribute to an expanding pool of patients who may potentially benefit from CAR T-Cell therapy, thereby expanding the market for this treatment. The top pharmaceutical entities presently operating in the market are Gilead Sciences (Kite Pharma), Novartis, Bristol Myers Squibb, Celgene, Johnson & Johnson, Cellectis, Atara Biotherapeutics, Adaptimmune Therapeutics, Poseida Therapeutics and UCAR-T.
UK Medication Access Programs Market Analysis
The UK Medication Access Programs Market was valued at $142.7 Mn in 2023 and is predicted to grow at a CAGR of 12.6% from 2023 to 2030, to $327.5 Mn by 2030. The key drivers of this industry include the aging population, government policies, and technological advancements. The industry is primarily dominated by players such as Gilead Sciences, Takeda Pharmaceuticals, Pfizer, and Novartis among others.
Canada Physiotherapy Equipment Market Analysis
The Canada Physiotherapy Equipment Market was valued at $1,672 Mn in 2023 and is predicted to grow at a CAGR of 7.2% from 2023 to 2030, to $2,720.19 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are Medelco, Ortho Canada, Enraf-Nonius BV, and Body Best among others.
Canada Dental Consumables Market Analysis
The Canada Dental Consumables Market was valued at $2704 Mn in 2023 and is projected to grow at a CAGR of 8.0% from 2023 to 2023, to $4634.2 Mn by 2030. The key drivers of this industry growing dental care needs, technological advancements, expanding dental infrastructure, increasing disposable incomes, public health initiatives, dental tourism, rising consumption of sugary and starchy foods, rise in unhealthy eating habits due to rising urbanization, changing living standards. The industry is primarily dominated by players such as Dentsply Sirona, 3M, Straumann Holding, Henry Schein, Patterson Companies among others.
Canada Patient Adherence Programs Market Analysis
The Canada Patient Adherence Programs Market was valued at $1036.5 Mn in 2023 and is predicted to grow at a CAGR of 18% from 2023 to 2030, to $3301.7 Mn by 2030. The key drivers of the market include increasing non-adherence, technological innovations, and cost containment. The prominent players of the Canada Patient Adherence Programs Market are Clearway Health, McKesson Canada, Bayshore Healthcare, Ontario Pharmacists Association (OPA), and the Canadian Agency for Drugs and Technologies in Health (CADTH), among others.
Canada Cardiac Resynchronization Therapy Market
Canada Cardiac Resynchronization Therapy Market valued at $384 Mn in 2022, projected to reach $567 Mn by 2030 with a 5% CAGR. The rising global prevalence of heart failure, driven by aging populations and lifestyle-related cardiovascular diseases, serves as a key growth driver for the Cardiac Resynchronization Therapy (CRT) market. Currently, leading pharmaceutical companies in this market include Abbott, Biotronik, Boston Scientific, Medtronic, St. Jude Medical, Sorin Group, Siemens Healthineers, Philips Healthcare, GE Healthcare, and Esaote.
Canada Cardiac Arrhythmia Therapeutics Market
Canada Cardiac Arrhythmia Therapeutics Market valued at $576 Mn in 2022, projected to reach $904 Mn by 2030 with a 5.8% CAGR. The key drivers of this industry include the rising prevalence of CVDs, technological advancements, and supportive government initiatives. The industry is primarily dominated by players such as Abbott, Medtronic, GE, Pfizer, Johnson & Johnson, Siemens, and Biosense Webster among others.
Canada LASIK Surgery Market Analysis
Canada LASIK Surgery Market was valued at $282.40 Mn in 2023 and is predicted to grow at a CAGR of 5.21% from 2023 to 2030, to $402.96 Mn by 2030. The key drivers of this industry include high prevalence, growing disposable income, and increasing marketing. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.
Canada Medical Digital Imaging System Market Analysis
The Canada Medical Digital Imaging System Market was valued at $2440 Mn in 2023 and is predicted to grow at a CAGR of 8.2% from 2023 to 2030, to $4236.24 Mn by 2030. The key drivers of this industry include high prevalence of chronic disease, aging population, and technology advancements. The industry is primarily dominated by players such as Siemens, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.
Canada Breastfeeding Accessories Market Analysis
Canada Breastfeeding Accessories Market was valued at $200.80 Mn in 2023 and is predicted to grow at a CAGR of 6.80% from 2023 to 2030, to $318.25 Mn by 2030. The key drivers of this industry include early disease detection, personalized medicine, and government funding. The industry is primarily dominated by Medala, Elvie, Willow Innovations, and Koninklijke Philips among others.
Canada Hospital Market Analysis
The Canada Hospital Market was valued at $439.96 Bn in 2023 and is predicted to grow at a CAGR of 7.6% from 2023 to 2030, to $734.69 Bn by 2030. The key drivers of this industry rise in the geriatric population, technological advancements, and government funding. The key players in the industry are Vancouver Coastal Health, Hamilton Health Sciences, London Health Sciences Centre, and Queen Elizabeth II Health Sciences Centre among others.
Canada Hemodialysis Equipment Market Analysis
The Canada Hemodialysis Equipment Market was valued at $1129.6 Mn in 2023 and is projected to grow at a CAGR of 7.6% from 2023 to 2023, to $1886.3 Mn by 2030. The key drivers of this industry are increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth. The industry is primarily dominated by players such as Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic among others.